Clinical trials / NCT07435129
NCT07435129Phase 2Recruiting

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Study sponsor: Scholar Rock, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2028-06Estimated
Enrollment · participants60Estimated
Source updated2026-09-02Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source